Clinical Trial

Validation and Assessment of Novel Morphology-Voltage-P-wave Score for Diagnosing Left Ventricular Diastolic Dysfunction in Patients With Hypertension

Study acronym: VANESSA
Recruiting
View on ClinicalTrials.gov →
Summary
This study aimed to assess and validate the diagnostic utility of a novel Morphology-Voltage-P-wave Score (MVP Score) in identifying left ventricular diastolic dysfunction among patients with hypertension. Researchers will collect information of patient with hypertension and underwent transthoracal echocardiography assessment. The data consist of demographic data, clinical presentation, laboratory, and echocardiography result were collected by two investigators. Then, the data was analyzed by using IBM SPSS Statistics v26.
Trial Details
NCT Number NCT06779513
Lead Sponsor Universitas Diponegoro
Conditions Hypertension
Enrollment 50 participants
Start Date 2024-01-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-03-15 (estimated)
Updated on ClinicalTrials.gov 2025-01-16